The PARP1 Inhibitor Niraparib Represses DNA Damage Repair and Synergizes with Temozolomide for Antimyeloma Effects

por Shen, Hong-Yuan, Tang, Hai-Long, Zheng, Yan-Hua, Feng, Juan, Dong, Bao-Xia, Chen, Xie-Qun
Publicado 2022

BRD4 inhibitor nitroxoline enhances the sensitivity of multiple myeloma cells to bortezomib in vitro and in vivo by promoting mitochondrial pathway-mediated cell apoptosis

por Li, Guang, Zheng, Yan-Hua, Xu, Li, Feng, Juan, Tang, Hai-Long, Luo, Cheng, Song, Yan-Ping, Chen, Xie-Qun
Publicado 2020

Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis

por Zheng, Yan-Hua, Xu, Li, Cao, Chun, Feng, Juan, Tang, Hai-Long, Shu, Mi-Mi, Gao, Guang-Xun, Chen, Xie-Qun
Publicado 2019